Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Pelthos Therapeutics director Ezra M. Friedberg disposed of 558 shares of the company's common stock on April 2, 2026, under a Rule 10b5-1 plan to cover estimated tax liabilities tied to vesting restricted stock units. The combined transactions totaled $11,670. The company has reported a sharp quarterly earnings miss but showed sequential revenue g…
Global equity markets that were open ticked higher on Easter Monday as investors largely shrugged off escalating U.S. rhetoric toward Iran and a further jump in oil prices. Market participants cited resilience in early March U.S. data, modest moves in bond yields, and selective sector strength even as energy costs and regional tensions remain sourc…
Michele Kim Connors, general counsel of Ambiq Micro, completed two stock sales on April 2, 2026, disposing of a total of 811 shares for $21,209 to meet tax obligations associated with previously reported restricted stock units. The trades occurred at prices between $25.55 and $26.68. Ambiq Micro's shares have climbed 20% over the last week and curr…
Kym Maas, President of LE Consumer and Chief Commercial Officer at Lands' End, sold 1,440 shares of company stock on April 1, 2026, for $64,800. On the same day Maas received shares through the exercise of restricted stock units and a performance-based retention award at no cost, and disposed of additional shares to cover tax obligations. Separatel…
Steven M. Chaouki, TransUnion's President of U.S. Markets, sold 5,000 shares on April 2, 2026, under a pre-arranged Rule 10b5-1 plan for $350,000. The share price at execution was $70.00; the stock trades near its 52-week low and is down 19% year-to-date. TransUnion has completed an acquisition adding AI-enabled telecom capabilities and set medium-…
Pelthos Therapeutics director Peter Greenleaf sold 797 shares of company stock on April 2, 2026, under a pre-arranged 10b5-1 plan for $16,669. The company posted a fourth-quarter 2025 EPS well below expectations, though quarterly revenue and 2025 net product revenue climbed on the back of a mid-year product launch. Analyst coverage was unchanged in…
Director Barry M Smith disposed of 700 shares of The Ensign Group on April 2, 2026, under a Rule 10b5-1 plan, netting $137,655. The transaction occurred as the stock traded near $198, up 52% year-over-year; some analysis flags the equity as potentially overvalued with a P/E of 33.84. Separately, Ensign reported Q4 2025 adjusted EPS of $1.82, beatin…
Andrew Dakos, President and CEO of Total Return Securities Fund (NYSE:SWZ), bought a total of 4,963 shares across two transactions in early April for a combined reported outlay of $29,422. After these purchases Dakos holds 39,453 shares directly and 88,282 shares indirectly via a limited partnership. The fund currently trades close to its 52-week l…
TD Synnex Chief Financial Officer David Gregory Jordan sold 3,225 shares of common stock on April 6, 2026, for $189.46 per share, generating proceeds of $611,008. The transaction occurred while the stock traded close to its 52-week peak of $191.78 after a nearly 98% gain over the prior 12 months. Management buybacks and robust fiscal first-quarter …
The Centers for Medicare & Medicaid Services finalized a 2.48% average payment increase to private insurers offering Medicare Advantage plans for 2027, a substantially larger rise than the 0.09% proposed in January. CMS said the change will deliver more than $13 billion in additional payments to Medicare Advantage plans in 2027. Shares of UnitedHea…
Apogee Acquisition Corp has priced its initial public offering (IPO) of 15 million units at $10.00 each, expecting to raise $150 million. The units, to be traded on Nasdaq under the ticker AACPU, include Class A shares, warrants, and rights. The company aims to use proceeds to pursue mergers or acquisitions focusing on companies in advanced technol…
The U.S. Education Department announced it will terminate six resolution agreements that had been established to protect transgender students under Title IX, stating the deals were improperly reached. The Office for Civil Rights will no longer monitor or enforce agreements with five school districts and one college, and the department declined to p…
Melanie Carpenter, executive vice president and chief human resources officer of Mid America Apartment Communities Inc (MAA), executed multiple transactions in early April 2026 that included a sale of 731 shares for roughly $91,214 and other dispositions and acquisitions recorded on a Form 4 filing. The company also announced a quarterly dividend a…
United Therapeutics Corp CFO and Treasurer Edgemond James sold 7,762 shares on April 2, 2026, realizing roughly $5.6 million, and exercised options for 10,000 shares at $135.42 for $1,354,199. The trades were made under a Rule 10b5-1 plan. The company's shares have risen 93% over the past year and trade at $559.65, while multiple analysts raised pr…
United Therapeutics Chairperson and CEO Martine Rothblatt sold about $5.3 million of company stock on April 2, 2026, and exercised options to acquire additional shares. The transactions were disclosed on a Form 4 and executed under a 10b5-1 plan adopted in November 2025. The company has recently drawn analyst attention after positive Phase 3 TETON-…
Timothy Argo, Executive Vice President, Chief Strategy & Analysis at Mid-America Apartment Communities Inc (NYSE: MAA), reported sales and other equity transactions in early April 2026. The REIT also announced its quarterly dividend and has seen a mix of analyst price-target changes and ratings reflecting differing perspectives on rental-market dyn…
Jennifer Ladd Hanson, Chief People Officer of CarGurus, sold 567 shares of Class A common stock on April 2, 2026, for $33.04 per share, totaling $18,733. The transaction was carried out under a Rule 10b5-1 plan and the Form 4 was signed by Suzanne Murray as attorney-in-fact on April 6, 2026. After the sale Hanson holds 96,432 shares. The stock trad…
Carlos E. Evans, a director at Goldman Sachs BDC, acquired 50,000 shares of the company's common stock on April 2, 2026, investing $451,035 at a weighted average price of $9.0207. The purchase increases his direct holding to 64,446 shares. Goldman Sachs BDC reported a fourth-quarter 2025 EPS beat but slightly missed revenue expectations and recentl…
John Uczekaj, President and COO of AIRO Group Holdings, reported a sale of 3,415 shares on April 6, 2026, to satisfy tax withholding related to restricted stock unit vesting. The $30,176 transaction was executed at a weighted average price of $8.8364. The move comes as AIRO stock trades below its annual level and after the company reported Q4 2025 …
Amber Fairbanks, EVP of Property Management at Mid-America Apartment Communities (MAA), sold 711 shares on April 6, 2026, for about $88,683 under a 10b5-1 plan. The move follows an April 1 purchase and a tax-related disposal, and arrives as analysts trim price targets while the REIT offers a 4.9% yield and is viewed as overvalued by InvestingPro.
Dafna Sarnoff, Chief Marketing Officer of CarGurus, sold 5,445 shares of Class A common stock on April 2, 2026, for $33.04 per share, generating $179,902. After the trade she holds 134,369 shares. The transaction was completed under a Rule 10b5-1 trading plan. Separately, CarGurus reported 15% year-over-year total revenue growth for the fourth quar…
CarGurus Chief Technology Officer Matthew Todd Quinn sold 4,341 shares of Class A common stock on April 2, 2026, at $33.04 per share, realizing $143,426. The sale, executed under a Rule 10b5-1 trading plan, leaves Quinn with 246,098 shares. CarGurus shares trade at $34.75, the stock is up 27% over the last year but down 13% year-to-date, and the co…
Replimune Group Chief Commercial Officer Christopher Sarchi reported the sale of 6,500 shares of common stock on April 2, 2026, generating $52,065 at a weighted average price of $8.01. The transactions were conducted under a trading plan adopted December 15, 2025; Sarchi retains significant equity and option exposure. The company’s share price has …
U.S. stock benchmarks closed higher on Monday, propelled by gains in the Consumer Services, Oil & Gas and Technology sectors. The Dow Jones Industrial Average rose 0.35%, the S&P 500 added 0.45% and the NASDAQ Composite increased 0.54%. A mix of strong performances among several blue chips and outsized moves in small-cap names punctuated th…
Canadian equities closed modestly higher on Monday, with the S&P/TSX Composite rising 0.22% in Toronto. Gains were concentrated in Consumer Discretionary, Industrials and Energy names. MDA Ltd., First Quantum Minerals and Avino Silver & Gold were among the session's top performers, while Stella-Jones, Transcontinental and First Majestic Silver weig…
